- The trading volume and the market valuation of Alpine 4 have soared once again as retail investors seem optimistic an uplisting to NASDAQ is close.
- However, the fundamentals remain unimpressive and I doubt this can last.
- H1 pro forma financials included sales of just $32.1 million, meaning that Alt Labs is not even close to annualized sales of $40 million.
- The short borrow fee rate has dropped significantly since my first article and I'm changing my stance to bearish.
For further details see:
Revisiting Alpine 4 - NASDAQ Listing Could Be Close But The Fundamentals Still Look Weak And I Remain Bearish